Ronan Group 'bewildered and disappointed' as plan for Dublin's tallest building rejected

Developer Johnny Ronan’s development group has stated that it is ‘bewildered’ and ‘disappointed’ by the Bord Pleanála decision to refuse planning permission for its 22 storey tower at George's Quay in Dublin.

Ronan Group 'bewildered and disappointed' as plan for Dublin's tallest building rejected
Wed, 21 Mar, 2018 - 16:08

By Gordon Deegan

Latest: Developer Johnny Ronan’s development group has stated that it is ‘bewildered’ and ‘disappointed’ by the Bord Pleanála decision to refuse planning permission for its 22 storey tower at George's Quay in Dublin.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Explosion at Donegal service station Planning granted for new petrol station next to site of Creeslough tragedy
Michael Lyster remembered as ‘magic in human form’ at emotional memorial service Michael Lyster remembered as ‘magic in human form’ at emotional memorial service
AI prompt chat bot. Search website to generate data, text or image. Man using computer with artificial intelligence app. Virtual Mental health experts issue warning over AI 'therapy'
CourtsHeathrowPlace: DublinPlace: George's QuayPlace: Bord PleanalaPlace: Tara Street DART stationPlace: Dart InterchangePlace: GeorgePlace: Dublin City centrePlace: Tara-Street Dart stationPlace: River Liffey Conservation AreaPlace: O’Connell StreetPlace: College GreenPlace: Lord Edward StreetPlace: Five LampsPlace: Granby RowPlace: Frederick Street NorthPlace: Parnell Street NorthPlace: Henrietta StreetPlace: Kildare StreetPlace: Harcourt StreetPerson: Johnny RonanPerson: Gordon DeeganPerson: Gillian KanePerson: KaneOrganisation: Ronan GroupOrganisation: Bord PleanálaOrganisation: An Bord PleanálaOrganisation: Trinity College Campus
<p>Sodium valproate, manufactured by Sanofi and sold as Epilim, has been linked to a high risk of serious injury for babies in the womb. File picture</p>

Three more children settle Epilim sodium valproate cases

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited